Market Reports




Non Profits




Biotechnology News Magazine

HomeDiagnostic Testing

Diagnostic Testing

Hologic’s COVID-19 Tests Detect Omicron Variant

“We fully expect that SARS-CoV-2 will continue to evolve, as that is the natural path for viruses,” said Kevin Thornal, president of the Diagnostic Solutions Division at Hologic. “We designed our assays with this in mind, and as a result, we are confident that the Omicron variant will not impact the performance of our assays.”

Hologic to Host Innovative Product Experiences and Medical Education Sessions On-site and Virtually at RSNA 2021

Leader in women's health to showcase clinically proven solutions across the continuum of breast and skeletal health at annual meeting.

Hologic Announces European Launch of Genius™ Digital Diagnostics System for Cervical Cancer Screening

With the Genius Digital Diagnostics System, cutting-edge image analysis thoroughly interrogates every cell on a ThinPrep® Pap test image to curate a single view of the most clinically relevant objects.

Meridian Launches Innovative Air-Dryable™ qPCR Mixes Enabling Direct Detection of DNA or RNA from Urine Samples

Meridian developed these unique master mixes specifically to overcome the adverse effect of inhibitors present in crude urine samples that can affect the sensitivity of a molecular assay.

U.S. Based Pancreatic Cancer Action Network Informs Members About Immunovia’s Blood Test IMMray™ PanCan-d

"The Immunovia IMMray™ PanCan-d test is an important step for some patients to be diagnosed earlier, have more treatment options and live longer", said Julie Fleshman, JD, MBA, President and CEO of Pancreatic Cancer Action Network (PanCAN).

Sera Prognostics Partners With Anthem and HealthCore to Improve Outcomes for Preterm Babies

January 5, 2021 Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health through innovative precision biomarker approaches, together with leading health benefits company Anthem, Inc. and its HealthCore, Inc. subsidiary, an evidence generation company,...

Sight Diagnostics Expands to the Gulf Region through a Distribution Partnership with Phoenix Capital

Through the partnership, Sight will provide OLO analyzers – the company’s decentralized, lab-quality diagnostic technology – to medical centers across the Middle East to help providers make quick and informed treatment decisions.

ORTHO Optix Reader Receives CE Mark and Available in Countries That Accept the CE Mark

ORTHO Optix Reader is supported by Ortho Care™, Ortho's award-winning, holistic service and support solution, and is now available in countries that accept CE Mark.

Australia Based Rhinomed Is Developing a Nasal Swab

Rhinomed notes this new high-yielding nasal swab that can collect samples from the nose to test for the presence of upper respiratory tract diseases, including influenza and coronavirus strains.

BluSense Diagnostics Releases a COVID-19 Antibody Test

ViroTrack Sero COVID-19 IgA+IgM/IgG Ab has been evaluated in collaboration with Hvidovre hospital, demonstrating an exceptional laboratory-grade accuracy in 13 minutes.

Knowing Signs and Symptoms of Lyme Disease Is Critical for Early Detection and Treatment, Says Industry-Leader Quidel

Leading the way in Lyme disease testing is the innovative Sofia 2 Lyme FIA test. This in-office test provides a patient as well as his or her physician with indicative results within minutes as opposed to days, which has historically been the norm.

Ortho Clinical Diagnostics Receives 2nd Antibody CE Mark

The company are trusted partners of hospitals, hospital networks, blood banks, and labs around the world, serving the clinical laboratory and transfusion medicine communities with customized solutions that enhance clinical outcomes, improve lab performance, overcome staffing challenges and better manage costs.

By using this website you agree to accept Medical Device News Magazine Privacy Policy